Infectious agents and Crohn's disease

Clinical Microbiology and Infection

Volumn 5, Issue 10, 1999, Pages 601-604

  Bulois, Philippe ^a   Desreumaux, Pierre ^a   Neut, Christelle ^b   Darfeuille Michaud, Arlette ^c   Cortot, Antoine ^a   Colombel, Jean Frédéric ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CROHN DISEASE; ENVIRONMENTAL FACTOR; HELICOBACTER HEPATICUS; HEREDITY; HUMAN; INTESTINE FLORA; LISTERIA; MEASLES VIRUS; MYCOBACTERIUM; NOTE; PATHOGENESIS; PEYER PATCH; PRIORITY JOURNAL; VASCULITIS; YEAST;

HELICOBACTER HEPATICUS; LISTERIA; MEASLES VIRUS; MYCOBACTERIUM;

EID: 0032756333     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00415.x     Document Type: Article

References (28)

1. Sartor RB. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation. In Kirsner JB, Shorter RG, eds. Inflammatory bowel disease, 4th edn. Baltimore: Williams & Wilkins, 1995: 96-124.
2. Sartor RB. Enteric microflora in IBD: pathogens or commensals? Inflamm Bowel Dis 1997; 3: 230-5.
3. Van Kruiningen HJ. On the use of antibiotics in Crohn's disease. J Clin Gastroenterol 1995; 20: 310-16.
4. Colombel JF, Louvet B, Müller-Allouf H, Desreumaux P. Recent advances in the etiology of Crohn's disease. Environment and genetics. In Galmiche JP, Gournay J, eds. Recent advances in the pathophysiology of gastro-intestinal and liver diseases. Paris: John Libbey Eurotext, 1997: 109-31.
5. Chiodini RJ, Van Kruiningen HJ, Thayer Jr WR, Merkal RS, Coutu JA. Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease. Dig Dis Sci 1984; 29: 1073-9.
6. Prantera C, Kohn A, Mangiarotti R, Andreoli A, Luzi C. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with multiple antibiotic regimen. Am J Gastroenterol 1994; 89: 513-18.
7. Thomas GAO, Swift GL, Green JT, et al. Controlled trial of antituberculous chemotherapy in Crohn's disease: a five year follow up study. Gut 1998; 42: 497-500.
8. Wakefield AJ, Ekbom A, Dhillon AP, Pittilo RM, Pounder RE. Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 1995; 108: 911-16.
9. Ekbom A, Daszak P, Kraaz W, Wakefield AJ. Crohn's disease after in-utero measles virus exposure. Lancet 1996; 348: 515-17.
10. Liu Y, Van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of Listeria, Escherichia coli and Streptococcus antigens in Crohn's disease. Gastroenterology 1995; 108: 1396-404.
11. Haga Y, Funakoshi O, Kuroe K, et al. Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction. Gut 1996; 38: 211-15.
12. Touze Y, Dubucquoi S, Cortot A, Van Kruiningen HJ, Colombel JF. IgM-specific measles-virus antibody in families with a high frequency of Crohn's disease. Lancet 1995; 346: 967.
13. Metcalf J. Is measles infection associated with Crohn's disease? Br Med J 1998; 316: 166.
14. Van Kruiningen HJ, Colombel JF, Cartun RW, et al. An in depth-study of Crohn's disease in two French families. Gastroenterology 1993; 104: 351-60.
15. Chiba M, Fukushima T, Inoue S, Horie Y, Iizuka M, Masamune O. Listeria monocytogenes in Crohn's disease. Scand J Gastroenterol 1998; 33: 430-4.
16. Cahill R, Foltz CJ, Fox JG, Dangler CA, Powrie F, Schauer DB. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 1997; 65: 3126-31.
17. Sendid B, Colombel JF, Jacquinot PM, et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 1996; 3: 219-26.
18. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan combined with antineutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42: 788-91.
19. Sendid B, Quinton JF, Charrier G, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 1998; 93: 1306-10.
20. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180: 2359-64.
21. Sartor RB. The influence of normal microbial flora on the development of chronic intestinal inflammation. Res Immunol 1997; 148: 567-76.
22. Sartor RB. Postoperative recurrence of Crohn's disease: the enemy is within the fecal stream: Gastroenterology 1998; 114: 398-407.
23. Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis and arthritis in HLA-B27/human β2 microglobulin transgenic rats. J Clin Invest 1996; 98: 945-53.
24. Ambrose NS, Johnson M, Burden DW, Keighley RB. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery. BrJ Surg 1984; 71: 623-5.
25. Cartun RW, Van Kruiningen HJ, Pedersen CA, Berman MM. An immunocytochemical search for infectious agents in Crohn's disease. Modern Pathol 1993; 6: 212-19.
26. Onderdonk AB, Richardson JA, Hammer RE, Taurog JD. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immunol 1998; 66: 6022-3.
27. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998; 115: 1405-13.
28. Jallat C, Livrelli V, Darfeuille-Michaud A, et al. Escherichia coli strains involved in diarrhea in France: high prevalence and heterogeneity of diffusely adhering strains. J Clin Microbiol 1993; 31: 2031-7.